B RECENT DEVELOPMENTS
5 The applicant engaged new solicitors in June 2023 and new counsel more recently still (although it should be noted the identity of counsel briefed to take the matter to trial remains unclear).
6 On 26 July 2023, I made orders deferring the date by which the applicant was to provide a draft second further amended statement of claim (draft pleading) and listed the interlocutory application for leave to amend the pleading (amendment application) for hearing in August 2023.
7 When the amendment application came before the Court, it was apparent the evidence filed by the applicant in support of the application was deficient. As a result, I made orders allowing for further evidence to be filed and adjourning the amendment application to a date to be fixed.
8 In September 2023, the funder wrote to the Court raising concerns as to the applicant's ability to represent the interests of group members and sought a relisting. There was some suggestion the funder would terminate the funding agreement unless certain steps were taken by the applicant. I am now told commercial discussions are currently underway with both the existing funder and a new funder to secure ongoing funding.
9 At a case management hearing on 4 October 2023, the funder appeared seeking leave to intervene in the proceeding and foreshadowing an application seeking an order pursuant to s 33T of the Federal Court of Australia Act 1976 (Cth) (FCA Act) for replacement of the representative applicant, to be brought by a (yet to be identified) group member. I made orders granting leave to the funder to intervene on a limited basis and listing the matter today for any such replacement application to be heard or, in the event no such application was made, to hear the outstanding amendment application.
10 On 18 October 2023, my Associate received a communication from the funder's solicitor in the following terms:
Dear Associate
We refer to the above matter and the orders made on 4 October 2023 by his Honour (Orders), pursuant to which 421LF LLC (Funder) was granted leave to intervene in the proceeding for the purpose of bringing its interlocutory application …
Despite the Funder's best efforts to identify a lead for a Replacement Application (as defined in the Orders), the Funder has not yet confirmed a proposed replacement lead and a group member is not therefore in a position to file a Replacement Application by 5pm today in accordance with the Orders. Consistent with comments of the Funder's counsel at the case management hearing on 2 October 2023, the Funder respectfully requires further time to identity a proposed replacement lead to finalise a Replacement Application and evidence in support.
(Emphasis in original).
11 I did not accede to this request (which was opposed by the applicant and the National Australia Bank (NAB)) for two reasons.
12 First, the orders made on 4 October spoke for themselves. Those orders contemplated the fact that a replacement application may not be made and set out the course to be taken in such a scenario.
13 Secondly, my concerns in relation to the conduct of this proceeding have only intensified over time. I determined it would not be in the interests of group members to defer matters again without receiving a more detailed update on the underlying causes of ongoing delay.
14 Related to this second point, it must be borne in mind that the importance of the Court's protective and supervisory role in relation to group members should not be understated. At all stages during the currency of a representative proceeding, the Court must be alive to the interests of group members and, as part of the case management function, monitor whether the proceedings are conducted by a representative in a way which best facilitates the just resolution of disputes according to law and as quickly, inexpensively and efficiently as possible: Australian Securities and Investments Commission v Richards [2013] FCAFC 89 (at [7]-[8] per Jacobson, Middleton and Gordon JJ); LCM Funding Pty Ltd v Stanwell Corp Ltd [2022] FCAFC 103; (2022) 292 FCR 169 (at 175 [22] per Lee J).